Skip to main content

Table 1 Baseline Characteristics of Patients with Non-Small-Cell Lung Cancer EGFR Mutation by Choroidal Metastasis Status

From: Epidermal growth factor receptor-mutant non-small cell lung Cancer and Choroidal metastases: long-term outcome and response to epidermal growth factor receptor tyrosine kinase inhibitors

Variables

All n = 83

Choroidal metastases n = 7

Non-choroidal metastases n = 76

p-value

Age, years

 Mean

69

56

70

<  10−6

 Median (IQR)

69 (60–80)

57 (50–60)

71 (61–80)

Sex (%)

 Male

37 (45)

2 (29)

35 (46)

0.45

 Female

46 (55)

5 (71)

41 (54)

Smoking status (%)

 Current smoker

4 (5)

0 (0)

4 (5)

0.79

 Former smoker

35 (42)

4 (57)

31 (41)

 Never smoker

44 (53)

3 (43)

41 (54)

Subtype of EGFR mutations (%)

 Exon 19

37 (44)

3 (43)

34 (45)

1

 Exon 21

33 (40)

3 (43)

30 (39)

 Others

13 (16)

1 (14)

12 (16)

Co-mutation status (%)

 Yes

52 (62)

5 (71)

47 (62)

1

 No

29 (35)

2 (29)

27 (35)

 Unknown

2 (2)

0

2 (3)

Complex EGFR mutations (%)

 Yes

11 (13)

2 (29)

9 (12)

0.36

 No

70 (84)

5 (71)

65 (85)

 Unknown

2 (2)

0

2 (3)

TP53 co-mutation (%)

 Yes

40 (48)

4 (57)

36 (47)

0.76

 No

41 (50)

3 (43)

38 (50)

 Unknown

2 (2)

0

2 (3)

  1. IQR interquartile range
  2. EGFR epidermal growth factor receptor